StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Something's brewing, BUT...

<< Previous

Bullboard Posts

Next >>

Comment by cactuseskimoon Mar 31, 2021 2:49pm

151 Views

Post# 32915827

RE:RE:RE:Something's brewing, BUT...

I agree, I am realistically hoping for about 2.5-3 million in Covid testing revenues, news on continued expected growth in this area, and a good (not great) list of partners to go along with the Aristotle launch announcement.

Liked2Think wrote: I hope this isnt like the last time people had huge hopes on things. Pumped up too much and then good news turns out to just be not much in comparision.

Things are going too pumpy right now.

Im parinoid. Cool the jets a bit.

I dont want to hear from the bashers again on how we didnt make 20 million this quarter blah blah blah